|
1
|
World Health Organization: In: Guidelines
for the prevention, care and treatment of persons with chronic
hepatitis B infection. Geneva, World Health Organization, 2015.
|
|
2
|
Kurokawa T, Zheng YW and Ohkohchi N: Novel
functions of platelets in the liver. J Gastroenterol Hepatol.
31:745–751. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Minamino T, Ito Y, Ohkubo H, Shimuzu Y,
Kojo K, Nishizwa N, Amano H, Narumiya S, Koizumi W and Majima M:
Adhesion of platelets through thromboxane A(2) receptor signaling
facilitates liver repair during acute chemical-induced
hepatotoxicity. Life Sci. 132:85–92. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Meyer J, Lejmi E, Fontana P, Morel P,
Gonelle-Gispert C and Bühler L: A focus on the role of platelets in
liver regeneration: Do platelet-endothelial cell interactions
initiate the regenerative process? J Hepatol. 63:1263–1271.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nowatari T, Murata S, Fukunaga K and
Ohkohchi N: Role of platelets in chronic liver disease and acute
liver injury. Hepatol Res. 44:165–172. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Afdhal N, McHutchison J, Brown R, Jacobson
I, Manns M, Poordad F, Weksler B and Esteban R: Thrombocytopenia
associated with chronic liver disease. J Hepatol. 48:1000–1007.
2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Peck-Radosavljevic M: Thrombocytopenia in
liver disease. Can J Gastroenterol. 14 (Suppl D):60D–66D.
2000.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang L, Wang B, You H, Wu X, Zhou J, Ou X
and Jia J: Platelets' increase is associated with improvement of
liver fibrosis in entecavir-treated chronic hepatitis B patients
with significant liver fibrosis. Hepatol Int. 12:237–243.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Myers RP, De Torres M, Imbert-Bismut F,
Ratziu V, Charlotte F and Poynard T: MULTIVIRC Group. Biochemical
markers of fibrosis in patients with chronic hepatitis C: A
comparison with prothrombin time, platelet count, and age-platelet
index. Dig Dis Sci. 48:146–153. 2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Milovanovic Alempijevic T, Stojkovic
Lalosevic M, Dumic I, Jocic N, Pavlovic Markovic A, Dragasevic S,
Jovicic I, Lukic S, Popovic D and Milosavljevic T: Diagnostic
accuracy of platelet count and platelet indices in noninvasive
assessment of fibrosis in nonalcoholic fatty liver disease
patients. Can J Gastroenterol Hepatol. 2017(6070135)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yoneda M, Fujii H, Sumida Y, Hyogo H, Itoh
Y, Ono M, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, et al: Platelet
count for predicting fibrosis in nonalcoholic fatty liver disease.
J Gastroenterol. 46:1300–1306. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Garjani A, Safaeiyan A and Khoshbaten M:
Association between platelet count as a noninvasive marker and
ultrasonographic grading in patients with nonalcoholic Fatty liver
disease. Hepat Mon. 15(e24449)2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Garcia-Tsao G, Abraldes JG, Berzigotti A
and Bosch J: Portal hypertensive bleeding in cirrhosis: Risk
stratification, diagnosis, and management: 2016 practice guidance
by the American Association for the study of liver diseases.
Hepatology. 65:310–335. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bedossa P and Poynard T: An algorithm for
the grading of activity in chronic hepatitis C. The METAVIR
cooperative study group. Hepatology. 24:289–293. 1996.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wai CT, Greenson JK, Fontana RJ,
Kalbfleisch JD, Marrero JA, Conjeevaram HS and Lok AS: A simple
noninvasive index can predict both significant fibrosis and
cirrhosis in patients with chronic hepatitis C. Hepatology.
38:518–526. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sterling RK, Lissen E, Clumeck N, Sola R,
Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT,
Thomas DL, et al: Development of a simple noninvasive index to
predict significant fibrosis in patients with HIV/HCV coinfection.
Hepatology. 43:1317–1325. 2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Samiullah S, Qasim R, Khalid S, Hussain
BG, Mukhtair J and Akbar Y: Evaluation of creatinine-modified child
pugh score for predicting short-term prognosis of patients with
decompensated cirrhosis of liver as compare to original child pugh
score. J Ayub Med Coll Abbottabad. 21:64–67. 2009.PubMed/NCBI
|
|
18
|
Khokhar N: Serum aminotransferase levels
and platelet count as predictive factor of fibrosis and cirrhosis
in patients with chronic hepatitis C infection. J Pak Med Assoc.
53:101–104. 2003.PubMed/NCBI
|
|
19
|
Hsu CW, Liang KH, Lin CL, Wang TH and Yeh
CT: Platelet counts modulate the quantitative relationship between
hepatitis B viral DNA and surface antigen concentrations: A
cross-sectional study of hematological, histological and viral
factors. BMC Infect Dis. 17(9)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Seto WK, Wong DK, Fung J, Ip PP, Yuen JC,
Hung IF, Lai CL and Yuen MF: High hepatitis B surface antigen
levels predict insignificant fibrosis in hepatitis B e antigen
positive chronic hepatitis B. PLoS One. 7(e43087)2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Pan Y, Muheremu A, Wu X and Liu J:
Relationship between platelet parameters and hepatic pathology in
patients with chronic hepatitis B infection-a retrospective cohort
study of 677 patients. J Int Med Res. 44:779–786. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu DP, Lu W, Zhang ZQ, Wang YB, Ding RR,
Zhou XL, Huang D and Li XF: Comparative evaluation of GPR versus
APRI and FIB-4 in predicting different levels of liver fibrosis of
chronic hepatitis B. J Viral Hepat. 25:581–589. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li Q, Lu C, Li W, Huang Y and Chen L:
Globulin-platelet model predicts significant fibrosis and cirrhosis
in CHB patients with high HBV DNA and mildly elevated alanine
transaminase levels. Clin Exp Med. 18:71–78. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tanikawa AA, Grotto RM, Silva GF, Ferrasi
AC, Sarnighausen VC and Pardini MI: Platelet-derived growth factor
A mRNA in platelets is associated with the degree of hepatic
fibrosis in chronic hepatitis C. Rev Soc Bras Med Trop. 50:113–116.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yoshida S, Ikenaga N, Liu SB, Peng ZW,
Chung J, Sverdlov DY, Miyamoto M, Kim YO, Ogawa S, Arch RH, et al:
Extrahepatic platelet-derived growth factor-β, delivered by
platelets, promotes activation of hepatic stellate cells and
biliary fibrosis in mice. Gastroenterology. 147:1378–1392.
2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
de Franchis R: Baveno VI Faculty.
Expanding consensus in portal hypertension: Report of the Baveno VI
consensus workshop: Stratifying risk and individualizing care for
portal hypertension. J Hepatol. 63:743–752. 2015.PubMed/NCBI View Article : Google Scholar
|
